Clinical Trial Update: Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of Pimecrolimus Cream 1% in patients aged 3 months and older with mild-to-moderate atopic dermatitis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED